Avibactam Impurities - SZEB

Avibactam is a non-β-lactam β-lactamase inhibitor. The new drug application for avibactam in combination  was approved by the FDA on February 25, 2015, for the treatment of complicated urinary tract infection (cUTI) and complicated intra-abdominal infection (cUTI) caused by antibiotic-resistant pathogens ( cIAI), including those caused by multidrug-resistant Gram-negative bacterial pathogens. SZEB manufacture and furnish high quality Avibactam impurity for global markets. More information is available on the official website: https://www.ex-biotech.com. If you have any questions, please send an email to sale@ex-biotech.com. We are looking forward to cooperating with you.

The following are some of the impurities of Avibactam :